alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### §9592. Federal assistance

#### (a) In general

#### (1) Provision of Federal assistance

To carry out sections ______101, ______102, and ______103(a),1 the Under Secretary may provide Federal assistance to public sector entities and private sector entities in the form of grants or cooperative agreements.

#### (2) Notice

Not later than 120 days after the date on which amounts are appropriated to carry out this section, the Under Secretary shall, in accordance with subsection (b), broadly publish a statement regarding Federal assistance that will, or may, be provided under paragraph (1) during the fiscal year for which those amounts are appropriated, including—

(A) the actual, or anticipated, amount of Federal assistance that will, or may, be made available;

(B) the types of Federal assistance that will, or may, be made available;

(C) the manner in which Federal assistance will be allocated among public sector entities and private sector entities, as applicable; and

(D) the methodology used by the Under Secretary to make allocations under subparagraph (C).

#### (3) Consultation

The Under Secretary shall consult with public sector entities and private sector entities, as applicable, in deciding the amounts and types of Federal assistance to make available under paragraph (1).

#### (b) Publicity

In carrying out this section, the Under Secretary shall broadly publicize all opportunities for Federal assistance available under this section, including through the means required under section ______116. 1

(Pub. L. 117–58, div. K, title VII, §100702, Nov. 15, 2021, 135 Stat. 1465.)

#### **Editorial Notes**

#### References in Text

Sections ______101, ______102, and ______103(a), referred to in subsec. (a)(1), probably mean sections 100101, 100102, and 100103(a) of Pub. L. 117–58, which are classified to sections 9511, 9512, and 9513(a) of this title.

Section ______116, referred to in subsec. (b), probably means section 100116 of Pub. L. 117–58, which is classified to section 9526 of this title.

1 So in original. See References in Text note below.
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * *

CHRISTINE HARRISON

, *

* No. 15 -1064V Petitioner, * Special Master Christian J. Moran

*

v. * Filed: December 20 , 2017

* SECRETARY OF HEALTH * Stipulation; Influenza (“flu”) vaccine; AND HUMAN SERVICES, * demyelinating event; vasculitis; * amaurosis fugax; anisocria; fatigue; * weakness; tingling Respondent. *

* * * * * * * * * * * * * * * * * * * * *

Mark Sadaka, Mark T. Sadaka, LLC, Englewood, NJ, for Petitioner; Ryan D. Pyles, United States Dep’t of Justice, Washington, DC, for Respondent.

UNPUBLISHED DECISION 1

On December 15

, 2017, the parties filed a joint stipulation concerning the petition for compensation filed by Christine Harrison on September 22, 2015

. Petitioner alleged that the influenza (“flu”) vaccine she received on September 25, 2012, which is contained in the Vaccine Injury Table (the “Table”), 42 C .F.R. §100.3(a), caused her to suffer demyelinating event, vasculitis, amaurosis fugax, anisocria, fatigue, weakness, tingling in her mouth, face, hand, leg, feet, and pain in the head, face, and legs

. Petitioner further alleges that she suffered the residual effects of this injury for more than six months. Petitioner represents that there has been no prior award or settlement of a civil action for damages on her behalf as a

result of her condition.

1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services) , requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special master will appear in the document posted on the website.2

Respondent denies that the vaccines either caused or significantly aggravated petitioner ’ s alleged injuries or any other injury, and denies that petitioner's current disabilities are the result of a vaccine-related injury

.

Nevertheless, the parties agree to the joint stipulation, attached hereto. The undersigned finds said stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.

Damages awarded in that stipulation include:

A lump sum payment of $ 90 ,000.00 in the form of a check payable to petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).

In the absence of a motion for review filed pursuant to RCFC, Appendix B, the clerk is directed to enter judgment in case 15 -1064V according to this decision and the attached stipulation. 2

IT IS SO ORDERED

.

s/Christian J. Moran
Christian J. Moran Special Master

2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each party filing a notice renouncing the right to seek review by a United States Court of Federal Claims judge.
Title III AFP Reporting Requirements

Title III of the Assistive Technology Act of 1998 (P.L. 105-395)

SEC. 307. ANNUAL REPORT

Not later than December 31 of each year, the Secretary shall submit a report to 

the Committee on Education and the Workforce of the House of Representatives 

and the Committee on Labor and Human Resources of the Senate describing the 

progress of each alternative financing program funded under this title toward 

achieving the objectives of this title. The report shall include information on—

1) the number of grant applications received and approved by the Secretary 

under this title, and the amount of each grant awarded under this title;

2) the ratio of funds provided by each State for the alternative financing 

program of the State to funds provided by the Federal Government for the 

program;

3) the type of alternative financing mechanisms used by each State and the 

community-based organization with which each State entered into a 

contract, under the program; and

4) the amount of assistance given to consumers through the program (who 

shall be classified by age, type of disability, type of assistive technology 

device or assistive technology service financed through the program, 

geographic distribution within the State, gender, and whether the 

consumers are part of an underrepresented population or rural 

population).

34 CFR part 75.720 Financial and Performance Reports

(a) This section applies to the reports required under—

1) 34 CFR 74.51 (Monitoring and reporting program performance) and 34 

CFR 74.52 (Financial reporting); and

2) 34 CFR 80.40 (Monitoring and reporting program performance) and 34 

CFR 80.41 (Financial reporting).

(b) A grantee shall submit these reports annually, unless the Secretary allows 

less frequent reporting.
DOCUMENTS 

❑ Photocopied veterinary

records

❑ Rabies certificate

❑ Vaccinations

❑ Medical summary

❑ Prescriptions for

medications

❑ Most recent heartworm

test result (dogs)

❑ Photocopied registration

information (ex: proof of

ownership or adoption

records)

❑ Pet description(s) (ex: breed,

sex, color, weight)

❑ Recent photographs for

each of your pets

❑ Waterproof container for

documents

❑ Microchip information

(ex: microchip number,

name and number of the

microchip company)

❑ Your contact information

(phone numbers and

addresses for your family

and friends or relatives you

may be staying with)

CS295562-A

WATER, FOOD, MEDICATIONS

❑ 2-week supply of food for

each animal stored in

waterproof containers

❑ 2-week supply of water for

each animal

❑ Non-spill food and water

dishes

❑ Manual can opener

❑ Feeding instructions for

each animal

❑ 2-week supply of any

medications (if applicable)

❑ Medication instructions

(if applicable)

❑ One month supply of flea,

tick, and heartworm

preventative

OTHER SUPPLIES

❑ Leash, collar with ID, and

harness

❑ Toys

❑ Appropriate-sized pet carrier

with bedding, blanket, or

towel

❑ Pet first aid book and first

aid kit

❑ Cleaning supplies

for accidents

(paper towels,

plastic bags,

disinfectant)

PET DISASTER KIT CHECKLIST
CS295562-A

PET DISASTER KIT CHECKLIST

DOCUMENTS 

❑ Photocopied veterinary 

records

❑ Vaccinations

❑ Medical summary

❑ Rabies certificate

❑ Prescription for 

medications

❑ Most recent FeLV/FIV 

test result (cats)

❑ Photocopied registration 

information (ex: proof of 

ownership or adoption 

records)

❑ Pet description(s) (ex: breed, 

sex, color, weight)

❑ Recent photographs for each 

of your pets 

❑ Waterproof container for 

documents 

❑ Microchip information 

(ex: microchip number, 

name and number of the 

microchip company)

❑ Your contact information 

(phone numbers and 

addresses for your family 

and friends or relatives 

you may be staying with)

WATER, FOOD, MEDICATIONS

❑ 2-week supply of food for 

each animal stored in 

waterproof containers

❑ 2-week supply of water for 

each animal

❑ Non-spill food and water 

dishes

❑ Manual can opener

❑ Feeding instructions for 

each animal

❑ 2-week supply of any 

medications (if applicable)

❑ Medication instructions 

(if applicable)

OTHER SUPPLIES

❑ Collar with ID

❑ Litterbox and litter (cats)

❑ Pet first aid book and first 

aid kit

❑ Appropriate-sized pet carrier 

with bedding, blanket, or 

towel

❑ Cleaning supplies for 

accidents (paper towels, 

plastic bags, disinfectant)
#### In the Matter of Debraun M., a Child Alleged to be Neglected. Administration for Children’s Services, Respondent; Walter C., Appellant. (Proceeding No. 1.) In the Matter of Jermaine M., a Child Alleged to be Neglected. Administration for Children’s Services, Respondent; Walter C., Appellant. (Proceeding No. 2.)

[826 NYS2d 76]

In related child protective proceedings pursuant to Family Court Act article 10, the father appeals from a fact-finding order of the Family Court, Richmond County (McElrath, J.), dated May 20, 2005, which, after a hearing, found that he had neglected the subject children.

Ordered that the order is affirmed, without costs or disbursements.

The Family Court’s findings of neglect based on the father’s failure to provide proper supervision and guardianship, and locking out the older child from his home are supported by a preponderance of the evidence. By leaving a then-eight-year-old child unsupervised in a busy airport, and by changing the home locks to prevent the older child from coming home, the father placed the children in imminent risk of harm *(see Matter of Antonio NN.,*28 AD3d 826, 827-828 [2006]; *cf. Nicholson v Scoppetta,*3 NY3d 357, 368 [2004]). Further, the record amply supports the Family Court’s determination that the father’s *588explanation for the eight-year-old child wandering by himself at the airport lacked credibility.

Alternatively, the finding that the father neglected the eight-year-old son was sufficient to support a finding of derivative neglect as to his older son *(see Matter of Christina Maria C.,*89 AD2d 855 [1982]). Crane, J.P., Krausman, Spolzino and Skelos, JJ., concur.
<PAGE>   1
                                                                      Exhibit 23

Great Lakes Chemical Corporation and Subsidiaries

                  CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS We consent
to the incorporation by reference in this Annual Report (Form 10-K) of Great
Lakes Chemical Corporation of our report dated February 3, 1998, included in the
1997 Annual Report to Stockholders of Great Lakes Chemical Corporation.

Our audits also included the financial statement schedule of Great Lakes
Chemical Corporation listed in Item 14(a). This schedule is the responsibility
of the Company's management. Our responsibility is to express an opinion based
on our audits. In our opinion, the financial statement schedule referred to
above, when considered in relation to the basic financial statements taken as a
whole, presents fairly in all material respects the information set forth
therein.

We also consent to the incorporation by reference in Registration Statement
Number 33-02069 on Form S-3, dated December 11, 1985, in Post-Effective
Amendment Number 1 to the Registration Statement Number 33-02074 on Form S-8,
dated February 3, 1995, in Registration Statement Number 33-02075 on Form S-8,
dated December 11, 1985, in Registration Statement Number 33-42477 on Form S-3,
dated August 28, 1991, in Registration Statement Number 33-57589 on Form S-8,
dated February 3, 1995, and in Registration Statement Number 33-300543 on Form
S-8, dated January 30, 1996, of our report dated February 3, 1998, with respect
to the consolidated financial statements incorporated herein by reference, and
our report included in the preceding paragraph with respect to the financial
statement schedule included in this Annual Report (Form 10-K) of Great Lakes
Chemical Corporation for the year ended December 31, 1997.


                                      ERNST & YOUNG LLP


Indianapolis, Indiana
March 25, 1998
#### § 36.213 Relationship of subpart B to subparts C and D of this part.

Subpart B of this part sets forth the general principles of nondiscrimination applicable to all entities subject to this part. Subparts C and D of this part provide guidance on the application of the statute to specific situations. The specific provisions, including the limitations on those provisions, control over the general provisions in circumstances where both specific and general provisions apply.
|                 | /s/ Mark R. Baker                                                  |
|----------------------|--------------------------------------------------------------------|
| Date: March 16, 2015 | Mark R. Baker Chief Executive Officer(Principal Executive Officer) |
| Delaware                                                          |                                             | 000-23143               |       | 13-3379479                       |
|-------------------------------------------------------------------|--------------------------------------------------|-------------------------|------------|----------------------------------|
| (State or other jurisdictionof incorporation)                     |                                             | (CommissionFile Number) |       | (IRS EmployerIdentification No.) |
|                                                              |                                             |                    |       |                             |
|                                                              | 777 Old Saw Mill River Road, Tarrytown, New York |                    | 10591      |
|                                                              | (Address of principal executive offices)         |                    | (Zip Code) |
| Registrant's telephone number, including area code (914) 789-2800 |

----

| Item 2.01. | Completion of Acquistion or Disposition of Assets. |
|------------|----------------------------------------------------|
| Item 9.01. | Financial Statements and Exhibits. |
|------------|------------------------------------|
| Exhibit No. | Description |
|-------------|-------------|
| 99.1   | Press Release dated November 24, 2015. |
|------------------|---------------------------------------------|

----

|   | PROGENICS PHARMACEUTICALS, INC. |
|--------|---------------------------------|
|   | By:                             | /s/ PATRICK FABBIO |
|   |                            | Patrick Fabbio |
|   |                            | Chief Financial Officer |
|   |                            | (Principal Financial and Accounting Officer) |
Exhibit






EXHIBIT 10.56




AMENDMENT 2
EMPLOYMENT AGREEMENT
THIS AMENDMENT 2 (“Amendment 2”) TO THE EMPLOYMENT AGREEMENT (“Agreement”) by and between LMI Aerospace, Inc., a Missouri corporation, its successors, and assigns (“Corporation”), and DANIEL G. KORTE (“Employee”) is entered into as of January 6, 2016. 
		
	1.
	The purpose of this Amendment is to revise certain terms and conditions of the Agreement as set forth below.


		
	2.
	Section 7(B)(ii) of the Agreement is hereby removed and replaced with the following:




For the purposes of this subsection 7(B), “Good Reason” shall include, in addition to the definition set forth in Section 6(C), the occurrence of any of the following after a Change in Control: (1) an involuntary reduction or diminution of Employee’s title, duties, authority, reporting relationship or responsibilities relative to Employee’s title, duties, authority, reporting relationship or responsibilities in effect immediately prior to such reduction;  (2) a material reduction in Employee’s salary, bonus opportunity or benefits; (3) requiring Employee to relocate his primary work location more than fifty (50) miles from Employee’s then-present location; (4) Employee is not the President and Chief Executive Officer of the ultimate parent entity of Corporation; or (5) Employee does not report  directly to the board of directors of the ultimate parent entity of Corporation.


		
	3.
	Section 7(B)(iii) of the Agreement is hereby removed in its entirety. 




		
	4.
	Section 20 of the Agreement is hereby removed and replaced with the following:




Survival.  All of those provisions of this Agreement that require performance by either party following termination of Employee’s employment hereunder as well as all provisions contained within Section 7(B) shall survive any termination of this Agreement.


		
	5.
	All other terms of the Agreement remain unchanged.




IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first set forth above.
CORPORATION:                                     LMI AEROSPACE, INC.




                                                        By:         /s/ Judith W. Northup
JUDITH W. NORTHUP
Chairperson, Compensation Committee
Board of Directors
LMI Aerospace, Inc.




EMPLOYEE:                                           /s/ Daniel G. Korte
DANIEL G. KORTE
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JAN-03-1998
<PERIOD-START>                             DEC-28-1996
<PERIOD-END>                               JAN-03-1998
<CASH>                                          57,663
<SECURITIES>                                         0
<RECEIVABLES>                                   16,128
<ALLOWANCES>                                     1,210
<INVENTORY>                                    188,767
<CURRENT-ASSETS>                               276,061
<PP&E>                                       1,170,310
<DEPRECIATION>                                 392,401
<TOTAL-ASSETS>                               1,227,190
<CURRENT-LIABILITIES>                          255,188
<BONDS>                                        311,537
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        31,754
<OTHER-SE>                                     569,275
<TOTAL-LIABILITY-AND-EQUITY>                 1,227,190
<SALES>                                      3,226,433
<TOTAL-REVENUES>                             3,226,433
<CGS>                                        2,427,287
<TOTAL-COSTS>                                2,427,287
<OTHER-EXPENSES>                               675,305
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              26,425
<INCOME-PRETAX>                                 97,416
<INCOME-TAX>                                    37,769
<INCOME-CONTINUING>                             59,647
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    59,647
<EPS-PRIMARY>                                     1.41
<EPS-DILUTED>                                     1.40
        

</TABLE>
**EXHIBIT 3(i)(c)**

 

ARTICLES OF AMENDMENT TO THE AMENDED ARTICLES OF INCORPORATION OF ASP VENTURES CORP.

 

Pursuant to the provisions of Title XXXVI, Chapter 607.1006 of the Florida Statutes, the undersigned corporation, ASP Ventures Corp. adopts the following Articles of Amendment to its Amended Articles of Incorporation.

 

The following amendment to the Amended Articles of Incorporation dated May 14, 1998 was adopted by a majority of the stockholders of the corporation on May 11, 2007.

 

This amendment deletes Article IV of the Amended Articles of Incorporation in its entirety, providing for a new Article IV, as set forth below: 

 

**ARTICLE IV**

**SHARES**

 

**The capital stock of this corporation shall consist of 250,000,000 shares of common stock, $.001 par value.**

 

The number of shares of the corporation outstanding at the time this amendment was adopted and the number of shares entitled to vote thereon was 40,071,069. The number of shares voted for such amendment was 24,166,233. The number of votes cast for the amendment by the stockholders was sufficient for approval of same.

 

The increase in authorized common shares to 250,000,000 par value $0.001 will be effective on the filing of this amendment to the Amended Articles of Incorporation of ASP Ventures Corp. with the Florida Secretary of State.

 

Dated June 6, 2007

 

 

/s/ Nora Coccaro

Nora Coccaro

Chief Executive Officer

 

 

 

 

 

 

 

24

 

----
#### Richard Sandow, an Infant, by Milton Sandow, His Guardian ad Litem, et al., Appellants, v. Open Stair Dwelling Company, Inc., Respondent.

No opinion. Present — Martin, P. J., Townley, Glennon, Cohn and Callahan, JJ.
November 16, 2015 

Dear Mr. Cox: 

This letter is to inform you that the following information is missing from your petition (Docket 

No. FAA-2015-3302). This information is necessary for the Federal Aviation Administration 

(FAA) to process your petition. 

 Describe the aircraft make(s), model(s), and type(s)(i.e. - fixed-wing, rotorcraft, lighterthan-air) for the proposed UAS operation. The description(s) should include the 

maximum weight (including payload). This information can be located in the aircraft 

manual(s). 

Please submit the additional information (non-proprietary) to your docket at 

www.regulations.gov. Once your information has been submitted, please also send a copy of the 

requested information (and any proprietary information), as well as your comment tracking 

number from regulations.gov via e-mail to 333exemptions@faa.gov. If you want us to process 

your request any further, we must receive the information described above by 11/30/15. If we do 

not receive the information, we will close the docket without notifying you further. 

If you have any questions, please feel free to contact me at (202) 267-2999. 

Sincerely, 

/S/ 

Brenda Robeson 

Program Analyst